Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant germ cell neoplasm arising from the testis. It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations. Most patients present with a testicular mass, which may be associated with pain. More than half of the patients have metastatic disease at diagnosis. The form of treatment following radical orchiectomy is stage dependent.
Biomarker and diagnostic research for testicular embryonal carcinoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
48 publications have been identified in PubMed for testicular embryonal carcinoma. Research spans Case Report / Case Series (25%), Basic Science / Preclinical (25%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 8:52 AM UTC
Laboratory research | 12 | 25% |
Research summaries | 7 | 15% |
Testing and diagnosis research | 6 | 13% |
Disease patterns and progression | 6 | 13% |
Clinical study results | 3 | 6% |
New treatment approaches | 2 | 4% |
Lundager KS (2026). [PMID: 40395097](https://pubmed.ncbi.nlm.nih.gov/40395097/). *Andrology*. [Epidemiology / Natural History]
Yang J (2026). [PMID: 41924289](https://pubmed.ncbi.nlm.nih.gov/41924289/). *Front Pediatr*. [Case Report / Case Series]
Choiniere R (2026). [PMID: 41717809](https://pubmed.ncbi.nlm.nih.gov/41717809/). *Histopathology*. [Diagnostic / Biomarker]
Grossmann NC (2026). [PMID: 41176470](https://pubmed.ncbi.nlm.nih.gov/41176470/). *Urol Oncol*. [Clinical Trial Publication]
Michalova K (2026). [PMID: 41980879](https://pubmed.ncbi.nlm.nih.gov/41980879/). *Am J Surg Pathol*. [Basic Science / Preclinical]
Fichtner A (2026). [PMID: 41384700](https://pubmed.ncbi.nlm.nih.gov/41384700/). *Histopathology*. [Review / Meta-Analysis]
Ricci C (2026). [PMID: 40936013](https://pubmed.ncbi.nlm.nih.gov/40936013/). *Virchows Arch*. [Diagnostic / Biomarker]
Schraps N (2026). [PMID: 41820800](https://pubmed.ncbi.nlm.nih.gov/41820800/). *Cancer Med*. [Basic Science / Preclinical]
Janssen FW (2026). [PMID: 41998312](https://pubmed.ncbi.nlm.nih.gov/41998312/). *Commun Med (Lond)*. [Diagnostic / Biomarker]
Francesco P (2026). [PMID: 41731693](https://pubmed.ncbi.nlm.nih.gov/41731693/). *Tumori*. [Review / Meta-Analysis]